Home Biosimilar Antibodies Others Others antibody Orilanolimab (Anti-FcRn (FCGRT & B2M)) For research use only.
Not for use in humans.

Orilanolimab (Anti-FcRn (FCGRT & B2M))

Synonyms: SYNT001

Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.

Orilanolimab (Anti-FcRn (FCGRT & B2M))

Purity & Quality Control

≥99

Biological Activity

Description Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.

Product Details

CAS No. 2066544-85-0
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Orilanolimab (Anti-FcRn (FCGRT & B2M)) | Orilanolimab (Anti-FcRn (FCGRT & B2M)) supplier | purchase Orilanolimab (Anti-FcRn (FCGRT & B2M)) | Orilanolimab (Anti-FcRn (FCGRT & B2M)) cost | Orilanolimab (Anti-FcRn (FCGRT & B2M)) manufacturer | order Orilanolimab (Anti-FcRn (FCGRT & B2M)) | Orilanolimab (Anti-FcRn (FCGRT & B2M)) distributor